Romiti, G F, Proietti, M, Vitolo, M, Bonini, N, Fawzy, A M, Ding, W Y, Fauchier, L, Marin, F, Nabauer, M, Dan, G A, Potpara, T S, Boriani, G, Lip, G Y H, ESC-EHRA EORP-AF General Long-Term Registry Investigators, Joensen, A M, Gammelmark, A, Rasmussen, L H, Dinesen, P, Riahi, S, Venø, S K, Sorensen, B, Korsgaard, A, Andersen, K & Hellum, C F 2022, ' Clinical complexity and impact of the ABC (Atrial fibrillation Better Care) pathway in patients with atrial fibrillation : a report from the ESC-EHRA EURObservational Research Programme in AF General Long-Term Registry ', BMC Medicine, vol. 20, no. 1, 326, pp. 326 . https://doi.org/10.1186/s12916-022-02526-7 on behalf of the ESC-EHRA EORP-AF General Long-Term Registry Investigators 2022, ' Clinical complexity and impact of the ABC (Atrial fibrillation Better Care) pathway in patients with atrial fibrillation : a report from the ESC-EHRA EURObservational Research Programme in AF General Long-Term Registry ', BMC Medicine, vol. 20, no. 1, 326 . https://doi.org/10.1186/s12916-022-02526-7 BMC Medicine, 20(1):326. BioMed Central BMC Medicine, 20(1):326. BioMed Central Ltd. BMC medicine, 20(1):326. BioMed Central
European journal of clinical investigation, p. e13745 (2022) the ESC-EHRA EORP-AF Long-Term General Registry Investigators 2022, ' Impact of renal impairment on atrial fibrillation : ESC-EHRA EORP-AF Long-Term General Registry ', European Journal of Clinical Investigation, vol. 52, no. 6, e13745 . https://doi.org/10.1111/eci.13745 European Journal of Clinical Investigation, 52(6):e13745 Ding, W Y, Potpara, T S, Blomström-Lundqvist, C, Boriani, G, Marin, F, Fauchier, L, Lip, G Y H, ESC-EHRA EORP-AF Long-Term General Registry Investigators, Joensen, A M, Gammelmark, A, Rasmussen, L H, Dinesen, P, Riahi, S, Venø, S K, Sorensen, B, Korsgaard, A, Andersen, K & Hellum, C F 2022, ' Impact of renal impairment on atrial fibrillation : ESC-EHRA EORP-AF Long-Term General Registry ', European Journal of Clinical Investigation, vol. 52, no. 6, e13745, pp. e13745 . https://doi.org/10.1111/eci.13745
Am J Hum Genet Motta, M, Pannone, L, Pantaleoni, F, Bocchinfuso, G, Radio, F C, Cecchetti, S, Ciolfi, A, Di Rocco, M, Elting, M W, Brilstra, E H, Boni, S, Mazzanti, L, Tamburrino, F, Walsh, L, Payne, K, Fernández-Jaén, A, Ganapathi, M, Chung, W K, Grange, D K, Dave-Wala, A, Reshmi, S C, Bartholomew, D W, Mouhlas, D, Carpentieri, G, Bruselles, A, Pizzi, S, Bellacchio, E, Piceci-Sparascio, F, Lißewski, C, Brinkmann, J, Waclaw, R R, Waisfisz, Q, van Gassen, K, Wentzensen, I M, Morrow, M M, Álvarez, S, Martínez-García, M, De Luca, A, Memo, L, Zampino, G, Rossi, C, Seri, M, Gelb, B D, Zenker, M, Dallapiccola, B, Stella, L, Prada, C E, Martinelli, S, Flex, E & Tartaglia, M 2020, ' Enhanced MAPK1 Function Causes a Neurodevelopmental Disorder within the RASopathy Clinical Spectrum ', American journal of human genetics, vol. 107, no. 3, pp. 499-513 . https://doi.org/10.1016/j.ajhg.2020.06.018 American journal of human genetics, 107(3), 499-513. Cell Press
BMJ Global Health BMJ global health, London : BMJ Publishing Group, 2020, vol. 5, iss. 12, art. no. e003429, p. 1-14 BMJ Global Health, Vol 5, Iss 12 (2020)